Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sachiko
S
Ono
Miki
M
Tanioka
Akihiko
A
Fujisawa
Hideaki
H
Tanizaki
Yoshiki
Y
Miyachi
Yumi
Y
Matsumura
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000077157:Sorafenib; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib